These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15503649)

  • 1. Vitamin D analogs: novel therapeutic agents for cardiovascular disease?
    Reinhart GA
    Curr Opin Investig Drugs; 2004 Sep; 5(9):947-51. PubMed ID: 15503649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease in chronic kidney failure: is there a role for vitamin D analogs?
    Wu-Wong JR; Nakane M; Traylor L; Ruan X; Kroeger PE; Tian J
    Curr Opin Investig Drugs; 2005 Mar; 6(3):245-54. PubMed ID: 15816500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D analogs as therapeutic agents: a clinical study update.
    Wu-Wong JR; Tian J; Goltzman D
    Curr Opin Investig Drugs; 2004 Mar; 5(3):320-6. PubMed ID: 15083599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular disease in chronic kidney failure: the role of VDR activators.
    Wu-Wong JR; Tian J; Nakane M; Ma J; Fey TA; Kroeger P; Fryer RM; Reinhart GA
    Curr Opin Investig Drugs; 2006 Mar; 7(3):206-13. PubMed ID: 16555680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D resistance.
    Bouillon R; Verstuyf A; Mathieu C; Van Cromphaut S; Masuyama R; Dehaes P; Carmeliet G
    Best Pract Res Clin Endocrinol Metab; 2006 Dec; 20(4):627-45. PubMed ID: 17161336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of vitamin D in dermatology.
    Kragballe K
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S72-6. PubMed ID: 9344190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are vitamin D receptor activators useful for the treatment of thrombosis?
    Wu-Wong JR
    Curr Opin Investig Drugs; 2009 Sep; 10(9):919-27. PubMed ID: 19705334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of vitamin D in cardiovascular disease.
    Verhave G; Siegert CE
    Neth J Med; 2010 Mar; 68(3):113-8. PubMed ID: 20308705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D and cardiovascular disease.
    Nemerovski CW; Dorsch MP; Simpson RU; Bone HG; Aaronson KD; Bleske BE
    Pharmacotherapy; 2009 Jun; 29(6):691-708. PubMed ID: 19476421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of vitamin D3 in arterial blood pressure control].
    Bednarski R; Donderski R; Manitius J
    Pol Merkur Lekarski; 2007 Oct; 23(136):307-10. PubMed ID: 18293857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of parathyroid hypertensive factor secretion by vitamin D3 analogs in parathyroid cells derived from spontaneously hypertensive rats.
    Sutherland SK; Nemere I; Benishin CG
    J Cell Biochem; 2005 Sep; 96(1):97-108. PubMed ID: 15988762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D analogs: therapeutic applications and mechanisms for selectivity.
    Brown AJ; Slatopolsky E
    Mol Aspects Med; 2008 Dec; 29(6):433-52. PubMed ID: 18554710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal versus extrarenal activation of vitamin D in relation to atherosclerosis, arterial stiffening, and hypertension.
    Richart T; Li Y; Staessen JA
    Am J Hypertens; 2007 Sep; 20(9):1007-15. PubMed ID: 17765144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and identification of 1alpha-hydroxy-3-epi-vitamin D3, a potent suppressor of parathyroid hormone secretion.
    Brown AJ; Ritter CS; Weiskopf AS; Vouros P; Sasso GJ; Uskokovic MR; Wang G; Reddy GS
    J Cell Biochem; 2005 Oct; 96(3):569-78. PubMed ID: 16088954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure.
    Li YC; Qiao G; Uskokovic M; Xiang W; Zheng W; Kong J
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):387-92. PubMed ID: 15225806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D receptor ligands for osteoporosis.
    Cheskis BJ; Freedman LP; Nagpal S
    Curr Opin Investig Drugs; 2006 Oct; 7(10):906-11. PubMed ID: 17086935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells.
    Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL
    Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D compounds: activity against microbes and cancer.
    Gombart AF; Luong QT; Koeffler HP
    Anticancer Res; 2006; 26(4A):2531-42. PubMed ID: 16886661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic vitamin D3 treatment protects against neurotoxicity by glutamate in association with upregulation of vitamin D receptor mRNA expression in cultured rat cortical neurons.
    Taniura H; Ito M; Sanada N; Kuramoto N; Ohno Y; Nakamichi N; Yoneda Y
    J Neurosci Res; 2006 May; 83(7):1179-89. PubMed ID: 16521124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.